Jeena Sikho Lifecare launches Narie Xpert and Porush Xpert Ayurvedic products

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Jeena Sikho Lifecare launched six new Ayurvedic products on September 2, 2026
  • New range includes Narie Xpert and Porush Xpert in granule, syrup, and tablet forms
  • All products are targeted exclusively at the domestic Indian market
  • Disclosure made under SEBI LODR Regulation 30 and recent circulars
powered bylight_fuzz_icon
49903836

*this image is generated using AI for illustrative purposes only.

Jeena Sikho Lifecare launched six new Ayurvedic healthcare products on September 2, 2026. The company introduced the Narie Xpert and Porush Xpert ranges to expand its domestic wellness portfolio.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Product Portfolio Expansion

The new offerings target specific health concerns within the Ayurvedic segment. Each product line is available in three formats: granules, syrup, and tablets.

Product Name Format Size
Narie Xpert Granules 80g
Narie Xpert Syrup 500 ml
Narie Xpert Tablet 52 Tab
Porush Xpert Granules 80g
Porush Xpert Syrup 500 ml
Porush Xpert Tablet 52 Tab

Market Focus

All six products are designated for the domestic market only. The filing explicitly states that international launch details are not applicable at this stage.

The company operates over 120 Ayurveda clinics and hospitals. It positioned these launches as part of its broader strategy to provide drug-free healthcare solutions.

Historical Stock Returns for Jeena Sikho Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
+2.03%-0.51%-12.37%-15.61%-27.21%0.0%

How might the exclusive domestic focus of the Narie Xpert and Porush Xpert ranges impact Jeena Sikho Lifecare's revenue diversification strategy in the near term?

What is the projected timeline for potential international expansion, and what regulatory hurdles must be cleared for these Ayurvedic products to enter global markets?

How do analysts expect the integration of these new product lines into the company's 120+ clinic network to influence patient retention and average transaction values?

Jeena Sikho Lifecare approves FY26 report, fixes dividend record date

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Jeena Sikho Lifecare approved its FY26 annual report on August 31, 2026
  • Final dividend of ₹4.50 per share recommended, subject to AGM approval
  • Record date fixed for September 21, 2026, for dividend eligibility
  • 9th AGM scheduled for September 28, 2026, in Zirakpur
  • Book closure period runs from September 22 to September 28, 2026
powered bylight_fuzz_icon
49724805

*this image is generated using AI for illustrative purposes only.

Jeena Sikho Lifecare approved its annual report for FY26 and fixed the record date for the final dividend. The board confirmed a recommended payout of ₹4.50 per equity share.

The company’s Board of Directors held its meeting on August 31, 2026, in Zirakpur. The directors considered and approved the Annual Report for the financial year ended March 31, 2026. This document includes the Board’s Report, Management Discussion and Analysis, and Corporate Governance Report.

Dividend and Shareholder Dates

The board fixed Monday, September 21, 2026, as the record date to determine eligibility for the final dividend. This follows an earlier intimation from May 30, 2026, where the board recommended the ₹4.50 per share payout. The face value of each equity share is ₹2.

Payment of the final dividend will occur within the statutory period prescribed under the Companies Act, 2013, subject to approval by members at the upcoming general meeting.

Particulars Details
Recommended Final Dividend ₹4.50 per equity share
Face Value ₹2
Record Date September 21, 2026
Cut-off Date for E-voting September 21, 2026

AGM Schedule and Logistics

The company scheduled its 9th Annual General Meeting (AGM) for Monday, September 28, 2026. The meeting will commence at 12:00 noon at the First Floor, Parle G Godown, City Enclave, Zirakpur.

The register of members and share transfer books will remain closed from Tuesday, September 22, 2026, to Monday, September 28, 2026. This book closure period facilitates the AGM and dividend entitlement processes.

The board appointed Mr. Vivek Rawal, Proprietor of M/s. Rawal & Co., as the scrutinizer for the AGM. He will oversee the remote e-voting process and provide a report on the voting outcome.

Historical Stock Returns for Jeena Sikho Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
+2.03%-0.51%-12.37%-15.61%-27.21%0.0%

How does the ₹4.50 dividend payout ratio compare to Jeena Sikho Lifecare's historical averages and industry peers in the healthcare sector?

What key strategic initiatives or financial performance metrics will likely be highlighted in the Management Discussion and Analysis for FY26?

Could the upcoming AGM resolutions signal any changes in corporate governance or board composition that might impact future operations?

More News on Jeena Sikho Lifecare

1 Year Returns:-27.21%